AFT Pharmaceuticals Limited (NZE:AFT)
New Zealand flag New Zealand · Delayed Price · Currency is NZD
2.780
-0.040 (-1.42%)
Jun 6, 2025, 2:19 PM NZST
-11.46%
Market Cap 295.72M
Revenue (ttm) 208.02M
Net Income (ttm) 11.96M
Shares Out 104.87M
EPS (ttm) 0.11
PE Ratio 25.64
Forward PE 18.11
Dividend 0.02 (0.64%)
Ex-Dividend Date Jun 18, 2025
Volume 6,903
Average Volume 14,671
Open 2.810
Previous Close 2.820
Day's Range 2.780 - 2.810
52-Week Range 2.370 - 3.420
Beta 0.34
RSI 59.84
Earnings Date May 22, 2025

About AFT Pharmaceuticals

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development, marketing, and distribution of pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers products for use in the areas of allergy, gastrointestinal, cold and flu, digestive health, eye care, first aid, nail care, pain management, skin care, vitamins, and supplements, as well as other products. The company has collaboration with Belgium’s Hyloris Pharmaceuticals to develop a novel innovative injectable iron deficiency t... [Read more]

Sector Healthcare
Founded 1997
Employees 119
Stock Exchange New Zealand Stock Exchange
Ticker Symbol AFT
Full Company Profile

Financial Performance

In 2024, AFT Pharmaceuticals's revenue was 208.02 million, an increase of 6.45% compared to the previous year's 195.41 million. Earnings were 11.96 million, a decrease of -23.36%.

Financial Statements

News

There is no news available yet.